Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 study

著者: Hagop M. Kantarjian, Farhad Ravandi, Nicholas J. Short, Xuelin Huang, Nitin Jain, Koji Sasaki, Naval Daver, Naveen Pemmaraju, Joseph D. Khoury, Jeffrey L. Jorgensen, Yesid Alvarado, Marina Konopleva, Guillermo Garcia‐Manero, Tapan M. Kadia, Musa Yılmaz, Gautam Bortakhur, Jan A. Burger, Steven M. Kornblau, William G. Wierda, Courtney D. DiNardo, Alessandra Ferrajoli, Jovitta Jacob, Rebecca Garris, Susan O’Brien, Elias Jabbour - The Lancet 2018 被引用: 241